PubRank

Marie Kosco-Vilbois

Author PubWeight™ 27.41‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 TLR4/MD-2 monoclonal antibody therapy affords protection in experimental models of septic shock. J Immunol 2007 1.48
2 Neutralization of IFNgamma defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice. EMBO Mol Med 2009 1.44
3 Deriving a germinal center lymphocyte migration model from two-photon data. J Exp Med 2008 1.44
4 A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am J Physiol Gastrointest Liver Physiol 2009 1.39
5 Germinal center B cells govern their own fate via antibody feedback. J Exp Med 2013 1.36
6 Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice. Circulation 2006 1.31
7 Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis. Inflamm Bowel Dis 2010 1.28
8 Deep sequencing of phage display libraries to support antibody discovery. Methods 2013 1.11
9 Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro. Mol Cell Neurosci 2004 1.00
10 Pivotal involvement of Fcgamma receptor IIA in the neutralization of lipopolysaccharide signaling via a potent novel anti-TLR4 monoclonal antibody 15C1. J Biol Chem 2007 1.00
11 Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3. J Immunol 2003 0.99
12 CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice. Eur Heart J 2011 0.98
13 Effect of Toll-like receptor 4 blockade on pulmonary inflammation caused by mechanical ventilation and bacterial endotoxin. Exp Lung Res 2008 0.93
14 A homogeneous 384-well high-throughput binding assay for a TNF receptor using alphascreen technology. J Biomol Screen 2003 0.89
15 Chemokines derived from soluble fusion proteins expressed in Escherichia coli are biologically active. Biochem Biophys Res Commun 2005 0.88
16 Transferring the characteristics of naturally occurring and biased antibody repertoires to human antibody libraries by trapping CDRH3 sequences. PLoS One 2012 0.88
17 3D and 4D imaging of immune cells in vitro and in vivo. Histochem Cell Biol 2008 0.85
18 Robust recombinant FcRn production in mammalian cells enabling oriented immobilization for IgG binding studies. J Immunol Methods 2011 0.85
19 Long-term amelioration of established collagen-induced arthritis achieved with short-term therapy combining anti-CD3 and anti-tumor necrosis factor treatments. Arthritis Rheum 2012 0.81
20  De novo isolation of antibodies with pH-dependent binding properties. MAbs 2015 0.81
21 Comparing CDRH3 diversity captured from secondary lymphoid organs for the generation of recombinant human antibodies. MAbs 2013 0.79
22 Enhancement of islet engraftment and achievement of long-term islet allograft survival by Toll-like receptor 4 blockade. Transplantation 2015 0.79
23 Epitope-dependent inhibition of T cell activation by the Ea transgene: an explanation for transgene-mediated protection from murine lupus. J Immunol 2004 0.78
24 Combination therapies in the context of anti-CD3 antibodies for the treatment of autoimmune diseases. Swiss Med Wkly 2012 0.78
25 The 16th International Conference on Lymphatic Tissues and Germinal Centers in Immune Responses. Eur J Immunol 2009 0.77
26 Characterization of a surrogate murine antibody to model anti-human CD3 therapies. MAbs 2013 0.77
27 Rapid, simple and high yield production of recombinant proteins in mammalian cells using a versatile episomal system. Protein Expr Purif 2010 0.76
28 Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors. MAbs 2014 0.75
29 IL-17F co-expression improves cell growth characteristics and enhances recombinant protein production during CHO cell line engineering. Biotechnol Bioeng 2012 0.75